Origin and Systemic Classification
Atrial natriuretic peptide belongs to hormones synthesized outside classic endocrine glands. The heart exhibits hormonal activity as part of the diffuse endocrine system.
- Right atrium: Cardiomyocytes in this region secrete atrial natriuretic peptide (ANP, A-type natriuretic peptide).
- Heart ventricles: Produce other natriuretic hormones; B-type natriuretic peptide (BNP) is secreted by the ventricles in response to myocardial stretch caused by an excessive increase in circulating blood volume.
Other organs also possess endocrine functions: the kidneys (renin secretion by the juxtaglomerular apparatus and erythropoietin by interstitial cells), the gastrointestinal tract (APUD cells secreting polypeptide hormones), the central nervous system (neuroendocrine peptides such as endorphins), and the thymus. Prostaglandins, thromboxane, and prostacyclin are also classified as hormone-like substances.
Mechanism of Action at the Cellular Level
- Receptor type: Natriuretic peptides—atrial (ANP, A-type) and brain (BNP, B-type)—are ligands for guanylyl cyclase-linked receptors. This represents the smallest family of transmembrane receptors.
- Intracellular cascade: Ligand binding stimulates the intrinsic guanylyl cyclase activity of the receptor.
- Second messenger: Guanosine triphosphate (GTP) is converted into cyclic guanosine monophosphate (cGMP).
Physiological example: B-type natriuretic peptide is secreted by the ventricles in response to stretch from blood volume overload. Through elevated cGMP levels, it induces vasodilation and enhances sodium and water excretion.
Pathophysiology and Clinical Significance
In nephrotic syndrome, atrial natriuretic peptide acts as a key regulator of water and sodium homeostasis.
The paradox of edema development despite expanded or normal effective circulating volume is explained by the kidneys losing responsiveness to ANP, resulting in diminished biological activity within renal tissue.
Systemic homeostatic disturbances include:
- Development of hypo-oncotic edema with sodium and water retention;
- Hormonal imbalance: secondary hyperaldosteronism, increased plasma renin and catecholamine activity;
- Metabolic shifts: hyperlipidemia, trace element loss, and a hypercoagulable state.
Differential Terminology
The abbreviation "ANP" should not be confused with other medical terms, such as atypical pneumonia or other specialized neurological and systemic acronyms depending on the clinical context.